AXS-05 Results in Reduction in Major Depression Symptoms

Via Peters

New data indicates a positive future for AXS-05 (dextromethorphan-bupropion) as a potential treatment for patients with major depressive disorder. The drug, developed by Axsome Therapeutics, is a novel, oral investigational N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity. The results from the GEMINI phase 3 clinical trial show AXS-05 showed rapid, […]

NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer

Via Peters

FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today that results from a clinical trial of topical submicron particle paclitaxel (SOR007) in cutaneous metastases of breast cancer (CMBOC) have been published in Breast Cancer Research and Treatment. The research article entitled Phase 1/2 Study of Topical […]

Some teens skip Covid-19 vaccines, with deadly results

Via Peters

“I would send her articles. I would send her studies. I would send her whatever I thought might either scare her enough about Covid to get the vaccine or allay her concerns enough about the vaccine,” said Lee Stonum, 41, a public defender in Orange County, California. His mother, who […]

AstraZeneca Announces Positive Results for Enhertu in Treating HER2 Breast Cancer

Via Peters

Trastuzumab deruxtecan demonstrated clinically meaningful and statistically significant improvements in overall and progression-free survival, the company says. AstraZeneca announced positive results from the DESTINY-Breast04 phase 3 trial of trastuzumab deruxtecan (Enhertu, AstraZeneca, Daiichi Sankyo) in individuals with HER2-low unresectable and/or metastatic breast cancer, regardless of hormone receptor (HR) status versus […]